BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 11387010)

  • 1. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection.
    Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS
    Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
    Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
    Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel node biopsy in ductal carcinoma in situ patients.
    Pendas S; Dauway E; Giuliano R; Ku N; Cox CE; Reintgen DS
    Ann Surg Oncol; 2000; 7(1):15-20. PubMed ID: 10674443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
    J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.
    Cox CE; Pendas S; Cox JM; Joseph E; Shons AR; Yeatman T; Ku NN; Lyman GH; Berman C; Haddad F; Reintgen DS
    Ann Surg; 1998 May; 227(5):645-51; discussion 651-3. PubMed ID: 9605656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathologic analysis of sentinel lymph nodes in breast carcinoma.
    Hsieh PP; Ho WL; Yeh DC; Liu TJ; Wu CC; Lin JH; Wang SJ
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):744-50. PubMed ID: 11076431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy.
    Cohen LF; Breslin TM; Kuerer HM; Ross MI; Hunt KK; Sahin AA
    Am J Surg Pathol; 2000 Sep; 24(9):1266-72. PubMed ID: 10976701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer.
    Albertini JJ; Lyman GH; Cox C; Yeatman T; Balducci L; Ku N; Shivers S; Berman C; Wells K; Rapaport D; Shons A; Horton J; Greenberg H; Nicosia S; Clark R; Cantor A; Reintgen DS
    JAMA; 1996 Dec; 276(22):1818-22. PubMed ID: 8946902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer.
    Olson JA; Fey J; Winawer J; Borgen PI; Cody HS; Van Zee KJ; Petrek J; Heerdt AS
    J Am Coll Surg; 2000 Dec; 191(6):593-9. PubMed ID: 11129806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer?
    Teng S; Dupont E; McCann C; Wang J; Bolano M; Durand K; Peltz E; Bass SS; Cantor A; Ku NN; Cox CE
    Am Surg; 2000 Jun; 66(6):574-8. PubMed ID: 10888134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic examination of sentinel lymph nodes in breast cancer.
    Ku NN
    Surg Oncol Clin N Am; 1999 Jul; 8(3):469-79. PubMed ID: 10448690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of involvement of sentinel and nonsentinel lymph nodes in a Canadian population with breast cancer.
    Ramjeesingh R; Quan ML; Gardner S; Holloway CM
    Can J Surg; 2009 Feb; 52(1):23-30. PubMed ID: 19234648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node biopsy, an alternative to elective axillary dissection for breast cancer.
    Nwariaku FE; Euhus DM; Beitsch PD; Clifford E; Erdman W; Mathews D; Albores-Saavedra J; Leitch MA; Peters GN
    Am J Surg; 1998 Dec; 176(6):529-31. PubMed ID: 9926784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer?
    Reynolds C; Mick R; Donohue JH; Grant CS; Farley DR; Callans LS; Orel SG; Keeney GL; Lawton TJ; Czerniecki BJ
    J Clin Oncol; 1999 Jun; 17(6):1720-6. PubMed ID: 10561208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved axillary staging of breast cancer with sentinel lymphadenectomy.
    Giuliano AE; Dale PS; Turner RR; Morton DL; Evans SW; Krasne DL
    Ann Surg; 1995 Sep; 222(3):394-9; discussion 399-401. PubMed ID: 7677468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma.
    Turner RR; Ollila DW; Krasne DL; Giuliano AE
    Ann Surg; 1997 Sep; 226(3):271-6; discussion 276-8. PubMed ID: 9339933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node.
    Schreiber RH; Pendas S; Ku NN; Reintgen DS; Shons AR; Berman C; Boulware D; Cox CE
    Ann Surg Oncol; 1999; 6(1):95-101. PubMed ID: 10030421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of axillary sentinel lymph node biopsy by immunohistochemistry and multilevel sectioning in patients with breast carcinoma.
    Liu LH; Siziopikou KP; Gabram S; McClatchey KD
    Arch Pathol Lab Med; 2000 Nov; 124(11):1670-3. PubMed ID: 11079022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?
    Chu KU; Turner RR; Hansen NM; Brennan MB; Bilchik A; Giuliano AE
    Ann Surg; 1999 Apr; 229(4):536-41. PubMed ID: 10203087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Validation study of the sentinel lymph node (SLN) method in invasive breast carcinoma. Personal data and review of the literature].
    Langer I; Zuber M; Köchli OR; Kocher T; Müller-Brand J; Torhorst J; Harder F
    Swiss Surg; 2000; 6(3):128-36. PubMed ID: 10894014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.